NeurEx: digitalized neurological examination offers a novel high-resolution disability scale-Reference-Cited by-同舟云学术

NeurEx: digitalized neurological examination offers a novel high-resolution disability scale

Published:2018-09-24 Issue:10 Volume:5 Page:1241-1249
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Kosa Peter¹,Barbour Christopher¹²,Wichman Alison¹,Sandford Mary¹,Greenwood Mark²,Bielekova Bibiana¹

Affiliation:

1. Neuroimmunological Diseases Section (NDS); National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health; Bethesda Maryland

2. Department of Mathematical Sciences; Montana State University; Bozeman Montana

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acn3.640/fullpdf

Reference17 articles.

1. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS);Kurtzke;Neurology,1983

2. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH;Hauser;N Engl J Med,1983

3. A neurologic rating scale (NRS) for use in multiple sclerosis;Sipe;Neurology,1984

4. Development and validation of a neurological disability scale for patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): the IPEC-1 scale;Schmidt;Neurology,2012

5. Development of a multiple sclerosis functional composite as a clinical trial outcome measure;Cutter;Brain,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis;2024-04-10

2. A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological research;Journal of Neurology;2024-02-20

3. Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms;Nature Communications;2022-12-12

4. Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype;2022-10-17

5. Confounder-adjusted MRI-based predictors of multiple sclerosis disability;Frontiers in Radiology;2022-09-13